Stephen Michael Rothenberg

CIK: 0002022747

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

TYRA

Tyra Biosciences, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

TYRA
Tyra Biosciences, Inc.
May 28, 2026
Award(A)
Stock Option (Right to Buy)
Direct
13.2K shares-
TYRA
Tyra Biosciences, Inc.
May 29, 2025
Award(A)
Stock Option (Right to Buy)
Direct
22.2K shares-

		Type	Shares	Price		Ownership
May 28, 2026	TYRA Tyra Biosciences, Inc.	Award(A) Stock Option (Right to Buy)	13,160	-	-	Direct
May 29, 2025	TYRA Tyra Biosciences, Inc.	Award(A) Stock Option (Right to Buy)	22,200	-	-	Direct

1-2 of 2 transactions

About Rothenberg Stephen Michael

Rothenberg Stephen Michael (SEC CIK 0002022747) files insider reports with the SEC as Director of Tyra Biosciences, Inc. (TYRA).

Signal8 holds 2 ownership filings by Rothenberg Stephen Michael, all Form 4s, filed between Jun 2, 2025 and Jun 1, 2026. Those filings report 2 transactions, from May 29, 2025 to May 28, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Rothenberg Stephen Michael's filings is in CARLSBAD, CA.

Recent filings by Rothenberg Stephen Michael

May 28, 2026: Grant or award of TYRA derivative securities (Form 4, code A).
May 29, 2025: Grant or award of TYRA derivative securities (Form 4, code A).

Other insiders filing for Tyra Biosciences, Inc. (TYRA)

Harris Todd, President and CEO
Rueb Yuliya, Vice President, Finance (PAO)
Fuhrman Alan, Chief Financial Officer
RA CAPITAL MANAGEMENT, L.P., Director
Verjee Rehan, Director
Moran Susan, Director

How to read Form 4 transaction codes